Literature DB >> 20688243

Epidemiology of ANCA-associated vasculitis.

Eleana Ntatsaki1, Richard A Watts, David G I Scott.   

Abstract

The epidemiology of the antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV), comprising Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome, poses considerable challenges to epidemiologists. These challenges include the difficulty of defining a case with a lack of clear distinction between the different disorders, case capture, and case ascertainment. The AAV are rare and therefore a large population is required to determine the incidence and prevalence, and this poses questions of feasibility. Despite these difficulties a considerable body of data on the epidemiology of the AAV has been built in the past 20 years with an interesting age, geographic, and ethnic tropism gradually being revealed. Most of the data come from White populations of European descent, and the overall annual incidence is estimated at approximately 10-20/million with a peak age of onset in those aged 65 to 74 years. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20688243     DOI: 10.1016/j.rdc.2010.04.002

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  47 in total

Review 1.  Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?

Authors:  Jan Willem Cohen Tervaert; Jan Damoiseaux
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 2.  Pauci-immune crescentic glomerulonephritis in limited cutaneous systemic sclerosis.

Authors:  P T Chan; C C Mok
Journal:  Clin Rheumatol       Date:  2012-05-30       Impact factor: 2.980

3.  Antineutrophil cytoplasm antibody-positive pulmonary-renal syndrome in a patient with diffuse cutaneous systemic sclerosis.

Authors:  Lennart Tonneijck; Anisha Tanna; Charles D Pusey
Journal:  BMJ Case Rep       Date:  2013-06-13

4.  Epidemiology and Outcomes of Granulomatosis With Polyangiitis in Pediatric and Working-Age Adult Populations In the United States: Analysis of a Large National Claims Database.

Authors:  Sirada Panupattanapong; Dustin L Stwalley; Andrew J White; Margaret A Olsen; Anthony R French; Mary E Hartman
Journal:  Arthritis Rheumatol       Date:  2018-12       Impact factor: 10.995

5.  Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: a retrospective single-center study.

Authors:  Yan Hong; Pengxian Shi; Xia Liu; Liu Yang; Kang Li; Feng Xu; Shaoshan Liang; Zhengzhao Liu; Haitao Zhang; Yinghua Chen; Weixin Hu
Journal:  Clin Rheumatol       Date:  2019-02-08       Impact factor: 2.980

Review 6.  Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.

Authors:  C O S Savage
Journal:  Clin Exp Immunol       Date:  2011-05       Impact factor: 4.330

7.  Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles.

Authors:  Ying Hong; Despina Eleftheriou; Abdullah A K Hussain; Fiona E Price-Kuehne; Caroline O Savage; David Jayne; Mark A Little; Alan D Salama; Nigel J Klein; Paul A Brogan
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

8.  Outcome and treatment of elderly patients with ANCA-associated vasculitis.

Authors:  Maria Weiner; Su Mein Goh; Aladdin J Mohammad; Zdenka Hruskova; Anisha Tanna; Annette Bruchfeld; Daina Selga; Zdenka Chocova; Kerstin Westman; Per Eriksson; Charles D Pusey; Vladimir Tesar; Alan D Salama; Mårten Segelmark
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-22       Impact factor: 8.237

9.  Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.

Authors:  H Timlin; S M Lee; R L Manno; P Seo; Duvura Geetha
Journal:  Semin Arthritis Rheum       Date:  2015-02-20       Impact factor: 5.532

Review 10.  Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations.

Authors:  Buraa Kubaisi; Khawla Abu Samra; C Stephen Foster
Journal:  Intractable Rare Dis Res       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.